Key Considerations for Pharmacists Administering RSV Vaccines

The panelists provide guidance on how pharmacists should advise patients on recognizing RSV symptoms that require urgent medical attention.

EP: 1.Preventing RSV in Adults: Current Vaccination Options

EP: 2.Identifying Contraindications Before Administering RSV Vaccines

EP: 3.Strategies for Addressing Vaccine Hesitancy in RSV Patient Populations

EP: 4.Counseling Patients on RSV Vaccine Safety and Efficacy

EP: 5.Addressing Respiratory Vaccine Fatigue

EP: 6.Impact of Social Determinants of Health on Respiratory Syncytial Virus (RSV)

EP: 7.Raising RSV Awareness Among High-Risk Patient Populations

EP: 8.Challenges of Concurrent Administration: RSV and Other Vaccines

EP: 9.The Pharmacist's Role in Shared Decision-Making for RSV Vaccination

Now Viewing

EP: 10.Key Considerations for Pharmacists Administering RSV Vaccines

EP: 11.Unmet Needs in Prevention and Management of RSV

EP: 12.Empowering RSV Patients: Essential Vaccine Education Resources

EP: 13.Understanding RSV Infection Patterns and Seasonal Outbreaks

EP: 14.Closing Remarks on RSV Vaccinations

Related Videos

Related Content

Advertisement

January 15th 2025

mRESVIA RSV Vaccine Is a Key Area to Watch for Community Pharmacy in 2025

Kennedy Ferruggia, Assistant Editor

July 1st 2024

Key Considerations for the Effective Utilization of RSV Vaccines

Ashley Pugh, PharmD, BCACP Lauren B. Angelo, PharmD, MBA

January 7th 2025

FDA Requires Warning for Guillain-Barré Syndrome in Prescribing Information for RSV Vaccines

Aislinn Antrim, Managing Editor

January 7th 2025

Rise in RSV Infections Is Associated With a Decrease in Vaccine Hesitancy

Kennedy Ferruggia, Assistant Editor

January 2nd 2025

Study Suggests Weakened RSV Vaccine Response in Immunocompromised Individuals

Kennedy Ferruggia, Assistant Editor

December 23rd 2024

ASHP Midyear: Vaccination Among Older Adults Prevents Severe RSV Infections

Related Content

Advertisement

January 15th 2025

mRESVIA RSV Vaccine Is a Key Area to Watch for Community Pharmacy in 2025

Kennedy Ferruggia, Assistant Editor

July 1st 2024

Key Considerations for the Effective Utilization of RSV Vaccines

Ashley Pugh, PharmD, BCACP Lauren B. Angelo, PharmD, MBA

January 7th 2025

FDA Requires Warning for Guillain-Barré Syndrome in Prescribing Information for RSV Vaccines

Aislinn Antrim, Managing Editor

January 7th 2025

Rise in RSV Infections Is Associated With a Decrease in Vaccine Hesitancy

Kennedy Ferruggia, Assistant Editor

January 2nd 2025

Study Suggests Weakened RSV Vaccine Response in Immunocompromised Individuals

Kennedy Ferruggia, Assistant Editor

December 23rd 2024

ASHP Midyear: Vaccination Among Older Adults Prevents Severe RSV Infections